VMD FOI requests received 1 July to 31 December 2022
Published 22 September 2023
1. Information and Communications Technology (ICT) arrangements
ATI number | Summary |
---|---|
ATI0806 | Information on authority’s devices and services contract(s) |
ATI0808 | Information on authority’s devices and services contract(s) |
ATI0814 | Information on ICT devices /hardware /expenditure |
ATI0822 | Information on organisation’s contracts around ICT contract(s) |
ATI0832 | Details of call centre contracts and contracts |
ATI0838 | Information on organisation’s contracts around ICT contract(s) |
2. Authorisations
ATI number | Summary |
---|---|
ATI0805 | Information on cannabinoid containing veterinary products which are pending for a marketing authorisation |
ATI0811 | Information on Dorset’s Scullcap & Valerian tablets that allowed you to licence them for their use in the management of anxiety in cats and dogs |
ATI0820 | Information on the number of Redwater Fever (Babesiosis) vaccination doses issued over the last 10 years |
ATI0823 | Information on MRNA injections |
ATI0827 | Information on SICs issued for Gamaret |
ATI0833 | Information on which Sheep dips contained Cresylic Creosote in 1991 |
ATI0834 | Information on which Sheep dips contained Cresylic Creosote in 1989 |
ATI0835 | Information on which Sheep dips contained Cresylic Creosote in 1986 |
ATI0840 | Information of history of authorised products |
3. Pharmacovigilance
ATI number | Summary |
---|---|
ATI0799 | Report on the numbers of incidents relating to this drug |
ATI0800 | Information on adverse drug reactions reported for Simparica Trio |
ATI0801 | Information on moxidectin, spinosad, afoxolaner, lufenuron and flumethrin sales |
ATI0802 | Information of sales of fipronil, imidacloprid, fluralaner, selamectin, flumethrin, afoxolaner and spinosad |
ATI0803 | Usage/sales data relating to parasiticide APIs |
ATI0804 | Information on imidacloprid and fipronil products |
ATI0807 | Usage/sales data relating to parasiticide APIs |
ATI0810 | Usage/sales data relating to parasiticide APIs |
ATI0815 | Adverse reports on dogs and parasite control |
ATI0817 | Usage/sales data relating to parasiticide APIs |
ATI0821 | Usage/sales data relating to parasiticide APIs |
ATI0824 | Information of other FOI requests |
ATI0828 | Information on serious adverse events for endectocides |
ATI0836 | Information on adverse event reactions to canine vaccines, and sales of vaccines |
ATI0839 | Reports of adverse reactions in dogs since 2018 for a specific product |
ATI0841 | Reports of adverse reactions to authorised canine vaccines |
4. Residues
ATI number | Summary |
---|---|
ATI0837 | Information on antibiotics and chemicals |
5. Legislation
ATI number | Summary |
---|---|
ATI0829 | Information on which sheep dips contained Cresylic Creosote in 1990 |
ATI0830 | Information on Cresylic Creosote used in some scab-approved sheep dips, in 1990 |
6. Business Support
ATI number | Summary |
---|---|
ATI0809 | Information on grants |
ATI0812 | Information on organisation, contract’s register |
ATI0813 | Information on courier services |
ATI0816 | Information on the number of staff who are contractual home workers |
ATI0818 | Expenditure on equality, diversity, and inclusivity |
ATI0819 | Expenditure on equality, diversity, and inclusivity |
ATI0825 | Information on contracts and suppliers |
ATI0826 | Information on contracts and suppliers |
ATI0831 | Information on the 1990 membership of the Veterinary Products Committee |
ATI0842 | Information on the number of staff working at the organisation |